WCN25-1843 MYCOPHENOLATE MOFETIL VS TACROLIMUS IN PURE CLASS V LUPUS NEPHRITIS – A RANDOMISED COMPARATIVE STUDY

Among 60 patients, 45 patients had proliferative lupus.25 patients were in NIH Regimen and 20 patients in Eurolupus regimen.23 patients (92%) in NIH and 14 patients in Eurolupus(70) attained remission.2patients in NIH and 5 patients in Eurolupus had no response.8 patients in NIH(32%) and 6 patients (30%) in Eurolupus developed infections due to treatment.5 patients in Eurolupus and 9 patients in NIH had flare Conclusions: Significant proteinuria reduction achieved in NIH regimen compared to Eurolupus regimen.Higher rate of remission achieved in NIH regimen compared to Eurolupus regimen but statistically not significant(p0.190).Study on larger population may be needed to confirm our results.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2025-01-27
DOI
https://doi.org/10.1016/j.ekir.2024.11.392
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

WCN25-1843 MYCOPHENOLATE MOFETIL VS TACROLIMUS IN PURE CLASS V LUPUS NEPHRITIS – A RANDOMISED COMPARATIVE STUDY

Sanjana Sharma, Atanu Pal, Abhishek Vashisth, Arunansu Bandhyopadhyay
Kidney International Reports
Systemic Lupus Erythematosus Research
article

WCN25-1843 MYCOPHENOLATE MOFETIL VS TACROLIMUS IN PURE CLASS V LUPUS NEPHRITIS – A RANDOMISED COMPARATIVE STUDY

Sanjana Sharma, Atanu Pal, Abhishek Vashisth, Arunansu Bandhyopadhyay
article en

Abstract

Among 60 patients, 45 patients had proliferative lupus.25 patients were in NIH Regimen and 20 patients in Eurolupus regimen.23 patients (92%) in NIH and 14 patients in Eurolupus(70) attained remission.2patients in NIH and 5 patients in Eurolupus had no response.8 patients in NIH(32%) and 6 patients (30%) in Eurolupus developed infections due to treatment.5 patients in Eurolupus and 9 patients in NIH had flare Conclusions: Significant proteinuria reduction achieved in NIH regimen compared to Eurolupus regimen.Higher rate of remission achieved in NIH regimen compared to Eurolupus regimen but statistically not significant(p0.190).Study on larger population may be needed to confirm our results.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Kidney International ReportsVol. 10(2)
Institute of Post Graduate Medical Education and Research (IN)
Openalex Percentile: Top 98%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.